Sarah Cannon Cancer Center Clinical Trials 2022
15 Active Clinical Trials
Closest Location:
Sarah Cannon Cancer Center
· Nashville, TN
Trials at this site
LY2784544 for Blood Cancer
18+
All Sexes
Nashville, TN
This trial is testing a new drug for people with myeloproliferative neoplasms, which are diseases that cause too many blood cells to be produced.
Phase 2
Waitlist Available
Has No Placebo
Learn More
Sarah Cannon Cancer Center
Call 1-877-CTLilly (1-877-285-4559) or 1-317-615-4559 Mon- Fri 9 AM - 5 PM Eastern time (UTC/GMT -5 hours, EST)
Eli Lilly and Company
Carfilzomib + Lenalidomide + Dexamethasone with Stem Cell Transplant for Multiple Myeloma
18+
All Sexes
Nashville, TN
This trial is studying how well carfilzomib, lenalidomide, and dexamethasone before and after stem cell transplant works in treating patients with newly diagnosed multiple myeloma.
Phase 2
Waitlist Available
FDA Approved Drug
Learn More
Sarah Cannon Cancer Center
Andrzej Jakubowiak
Abemaciclib Combination Therapy for Advanced Breast Cancer
18+
Female
Nashville, TN
This trial is testing the safety of abemaciclib when used with other treatments for patients whose breast cancer has spread. Abemaciclib helps to stop cancer cells from growing by blocking certain proteins they need. The study aims to find out if this combination is safe for patients with advanced breast cancer.
Phase 1
Waitlist Available
Has No Placebo
Learn More
Sarah Cannon Cancer Center
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company
Atezolizumab After Chemotherapy for Lung Cancer
18+
All Sexes
Germantown, TN
This trial is testing a new cancer treatment against the current best treatment, to see if the new treatment is more effective in preventing the cancer from returning.
Phase 3
Waitlist Available
Has No Placebo
Learn More
Sarah Cannon Cancer Center
Clinical Trials
Hoffmann-La Roche
Ramucirumab/Merestinib + Chemotherapy for Biliary Tract Cancer
18+
All Sexes
Nashville, TN
This trial is testing ramucirumab, merestinib, or placebo in combination with cisplatin and gemcitabine to see if it can help treat people with advanced or metastatic biliary tract cancer.
Phase 2
Waitlist Available
FDA Approved Drug
Learn More
Sarah Cannon Cancer Center
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company
Abemaciclib + Tamoxifen for Metastatic Breast Cancer
18+
Female
Nashville, TN
This trial is testing abemaciclib, a new cancer drug, to see if it is safe and effective in treating women with metastatic breast cancer that is hormone receptor-positive and human epidermal growth factor receptor 2 negative.
Phase 2
Waitlist Available
Has No Placebo
Learn More
Sarah Cannon Cancer Center
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company
View All Trials at Sarah Cannon Cancer Center
Is this your site?
Every week patients are viewing your profile. Claim your page to easily update information, respond to patients, and more!
Claim Profile
Is this your site?
Every week patients are viewing your profile. Claim your page to easily update information, respond to patients, and more!
Claim This Site